Search Dental Tribune

Ivoclar and MALO CLINIC partner to advance implant dentistry and education

Partnership sealed: Representatives from Ivoclar and MALO CLINIC have signed the strategic collaboration agreement at Ivoclar’s headquarters in Schaan in Liechtenstein. (Image: Ivoclar)

Thu. 10. July 2025

save

SCHAAN, Liechtenstein: The Ivoclar Group, a leading manufacturer of integrated solutions for high-quality dental applications, and MALO CLINIC—internationally recognised for its evidence-based treatment concepts and as the pioneer of the All-on-4 treatment concept—have entered into a strategic partnership to advance innovative dental treatment approaches.

The collaboration aims to redefine research, development and education in dentistry. By combining Ivoclar’s expertise in dental materials and workflows with MALO CLINIC’s clinical and scientific leadership, the two companies intend to deliver comprehensive solutions that enhance efficiency, aesthetics and patient-centred care.

Driving progress in research, development and education

Building on an existing relationship, this new phase of cooperation brings together two core strengths: Ivoclar’s long-standing experience in developing innovative dental materials and systematic workflows, and MALO CLINIC’s clinical excellence along with its international research and training infrastructure.

“The cooperation with MALO CLINIC brings together product development, research and training from the outset―with the goal of creating innovative and practical solutions that sustainably improve everyday clinical practice for our customers,” said Markus Heinz, CEO of Ivoclar.

Joint innovation in implant restoration

The partnership will include joint research and development projects, clinical studies and collaborative training and education programmes. Existing offerings will be expanded with new concepts focused on the All-on-4 approach and implant-supported restorations. Initial joint studies on durable, aesthetic implant solutions using IPS e.max zirconium oxide are already being planned.

Pedro Alvarez, CEO of MALO CLINIC, said: “We are honoured to enter into this strategic partnership with Ivoclar. Together, we share the commitment to translating scientifically based innovations into daily practice. Our close collaboration in research and education will set new standards for quality and patient care.”

More information is available at ivoclar.com and maloclinics.com.

Tags:
To post a reply please login or register
advertisement
advertisement